Novo Nordisk is a Danish triple bottom line healthcare company that was founded in 1923 by a Nobel-prize winning scholar at the University of Copenhagen. Novo Nordisk is dedicated to promoting bioethical awareness, integrating environment assessments into all considerations across the value chain, and making their products available to those who need them as well as contributing to the development of sustainable healthcare infrastructure.
Novo Nordisk is passionate about its dedication to balancing social, financial, and environmental considerations, and as a testament to that they were recently recognized with the 2012 TakeAction award, which recognized their commitment to ensuring a steady supply of insulin and other medicines their manufacture to Syria in the country's time of chaos.
Contact Information
Novo Nordisk website
Novo Nordisk on Facebook
Novo Nordisk on Twitter
What's Driving This Trend
- Triple Bottom Line Healthcare
- Opportunity for healthcare companies to adopt a triple bottom line approach and integrate social, financial, and environmental considerations into their business strategies.
- Bioethical Awareness
- Opportunity for companies to promote bioethical awareness in healthcare by considering ethical implications in their products and services.
- Sustainable Healthcare Infrastructure
- Opportunity to contribute to the development of sustainable healthcare infrastructure, ensuring accessibility and long-term viability.
Who This Affects Most
- Healthcare
- Healthcare industry can adopt socially responsible practices, integrating social, financial, and environmental considerations into their operations.
- Pharmaceuticals
- Pharmaceutical companies can promote bioethical awareness and develop sustainable solutions in their manufacturing processes.
- Medical Equipment
- Medical equipment industry can contribute to the development of sustainable healthcare infrastructure by designing eco-friendly and accessible products.
